Almost a century ago, the novel Brave New World portrayed a future in which technology and medicine are integral parts of our lives. How far have we come? How far will we go? This opinion article discusses our advancement in disease diagnostics, with special focus on the interlinks between genome sequencing and machine learning.
Does the justice system oversee big pharma and its drug patent culture? Who does this culture benefit the most- pharma or the patients? Here is a case study in India where the generic drug manufacturers won against a major pharma company, with many seeing this as a victory for patients in terms of drug afforadability. Read on this opinion piece here…
Pneumonia affects hundreds of millions of people a year around the world and early detection of the disease is one of the most important preventative measures to bring the numbers down. CheXNet, a deep learning algorithm developed by scientists in Stanford, is one of the methods we can utilise machine learning for early detection of pneumonia.
Cell free fetal DNA (cffDNA) circulating in maternal blood was discovered back in 1997. It now shows promise in being used for non-invasive pre-natal screening to detect fetal chromosomal abnormalities and more. Read here for insights on the efficacy and advantages of this technique.
Stroke is considered a pandemic because of the number of people affected every year around the world. Complications arising from methods traditionally used in treatment of blockage of arteries - an underlying cause - have led to the birth of TransCarotid Artery Revascularisation (TCAR) method. This article brings you all you want to know about this promising innovation.
We all find one way or another to enhance our daily performance. What is the biology behind the methods we use? How do these methods affect healthy versus unhealthy individuals? In this article we bring you all you need to know about neuroenhancement.
At their minuscule sizes of billionths of a metre, nanoparticles and their use in medicine brings about the field of nanomedicine, a field that carries a potential that is everything but minuscule. Read on to find out just what nanomedicine means and why it's of 'giga' importance.
From diagnosing diseases to growing organs in miniature environments to effective delivery of drugs to their targets, microfludics opens the door to a big world of potential in medicine. Read the last of our microfludics series to discover how the simple process of flowing liquids through microchannels can harbour an explosive innovative potential.
Mimicking and understanding the environment molecules, cells and organs work in requires creative thinking and sublime engineering. Microfluidics technology is a product of such a process and makes it possible for researchers to achieve results that cannot be achieved by other means. Read the first instalment of our new 3-part series on microfluidics here to see what we mean.
Fixing genes, introducing them to a patient and making the patient's body accept the newly introduced genes are challenges we were not able to overcome until recently. Now, with the advance of genome editing techniques and the use of stem cells, we are closer than ever. Here we bring you the insight on how it would work to combine these two biological tools to fight disease.